Teshima, H.; Takigawa, H.; Kotachi, T.; Tsuboi, A.; Tanaka, H.; Yamashita, K.; Kishida, Y.; Urabe, Y.; Kuwai, T.; Ishikawa, A.;
et al. A Proton Pump Inhibitor Independently Elevates Gastrin Levels as a Marker for Metachronous Gastric Cancer After Endoscopic Submucosal Dissection. J. Clin. Med. 2024, 13, 6599.
https://doi.org/10.3390/jcm13216599
AMA Style
Teshima H, Takigawa H, Kotachi T, Tsuboi A, Tanaka H, Yamashita K, Kishida Y, Urabe Y, Kuwai T, Ishikawa A,
et al. A Proton Pump Inhibitor Independently Elevates Gastrin Levels as a Marker for Metachronous Gastric Cancer After Endoscopic Submucosal Dissection. Journal of Clinical Medicine. 2024; 13(21):6599.
https://doi.org/10.3390/jcm13216599
Chicago/Turabian Style
Teshima, Hajime, Hidehiko Takigawa, Takahiro Kotachi, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Yoshihiro Kishida, Yuji Urabe, Toshio Kuwai, Akira Ishikawa,
and et al. 2024. "A Proton Pump Inhibitor Independently Elevates Gastrin Levels as a Marker for Metachronous Gastric Cancer After Endoscopic Submucosal Dissection" Journal of Clinical Medicine 13, no. 21: 6599.
https://doi.org/10.3390/jcm13216599
APA Style
Teshima, H., Takigawa, H., Kotachi, T., Tsuboi, A., Tanaka, H., Yamashita, K., Kishida, Y., Urabe, Y., Kuwai, T., Ishikawa, A., & Oka, S.
(2024). A Proton Pump Inhibitor Independently Elevates Gastrin Levels as a Marker for Metachronous Gastric Cancer After Endoscopic Submucosal Dissection. Journal of Clinical Medicine, 13(21), 6599.
https://doi.org/10.3390/jcm13216599